Xenetic Biosciences Q2 2025 Earnings Narrowed Loss Beats Estimates as Pipeline Advances EPAM Q1 2026 Earnings EPS Beats Estimates by 183 Amid Uncertain Revenue Trends SII Q1 2026 Earnings EPS Surprises Upward Despite Broader Market Headwinds Remitly Q1 2026 Earnings Stellar EPS Beat Fuels Optimism Revenue Details Remain Undisclosed Astrana Health Inc Q1 2026 Earnings EPS Falls Short of Estimates Revenue Details Omitted JJSF Q1 2026 Earnings EPS Misses Estimates Despite Narrow Surprise Stock Edges Higher